The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: Analysis of 1259 National Marrow Donor Program donor-recipient pairs

Bone Marrow Transplantation

Volumn 25, Issue 4, 2000, Pages 385-393

  Hurley, C K ^a,m   Baxter Lowe, L A ^b,n   Begovich, A B ^c   Fernandez Vina, M ^d   Noreen, H ^e   Schmeckpeper, B ^d,f   Awdeh, Z ^g   Chopek, M ^d   Salazar, M ^d   Williams, T M ^h   Yunis, E J ⁱ   Kitajima, D ^j   Shipp, K ^j   Splett, J ^j   Winden, T ^j   Kollman, C ^j   Johnson, D ^k   Ng, J ^a,l   Hartzman, R J ^k   Hegland, J ^j  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c ROCHE MOLECULAR SYSTEMS   (United States)

^d AMERICAN RED CROSS   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g CBR Laboratories Inc   (United States)

^h UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

ⁱ DANA FARBER CANCER INSTITUTE   (United States)

^j NATIONAL MARROW DONOR PROGRAM   (United States)

^k Blood Centers of the Pacific   (United States)

^l NAVAL MEDICAL RESEARCH CENTER   (United States)

^m GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Bone marrow transplantation; HLA matching

Indexed keywords

HLA ANTIGEN CLASS 2; HLA D ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR1 ANTIGEN;

ALLELE; ALLOGRAFT; ARTICLE; BONE MARROW TRANSPLANTATION; CAUCASIAN; CONTROLLED STUDY; DATA BASE; GENE LOCUS; HLA MATCHING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 0034002281     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702161     Document Type: Article

References (37)

1. Devergie A, Apperley JF, Labopin M et al. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1997; 20: 11-19.
2. Davies SM, Shu XO, Blazar BR et al. Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome. Blood 1995; 86: 1636-1642.
3. Speiser DE, Tiercy JM, Rufer N et al. High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation. Blood 1996; 87: 4455-4462.
4. Anasetti C, Beatty PG, Storb R et al. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 1990; 29: 79-91.
5. Spencer A, Szydlo RM, Brookes PA et al. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient. Blood 1995; 86: 3590-3597.
6. Hansen JA. Development of registries of HLA-typed volunteer marrow donors. Tissue Antigens 1996; 47: 460-463.
7. Beatty PG, Mori M, Milford E. Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor. Transplantation 1995; 60: 778-783.
8. Mori M, Beatty PG, Graves M et al. HLA gene and haplotype frequencies in the North American population - The National Marrow Donor Program Donor Registry. Transplantation 1997; 64: 1017-1027.
9. Granja CB, Salazar M, Yunis EJ. Population genetics and human leukocyte antigen polymorphism. In: Tilney NL, Strom TB, Paul LC (eds). Transplantation Biology: Cellular and Molecular Aspects. Lippincott-Raven Publishers: Philadelphia. 1996, pp. 311-325.
10. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1996. Tissue Antigens 1997; 49: 297-321.
11. Petersdorf EW, Longton GM, Anasetti C et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995; 86: 1606-1613.
12. Keever CA, Leong N, Cunningham I et al. HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation. Bone Marrow Transplant 1994; 14: 137-145.
13. Baxter-Lowe LA, Eckels DD, Ash R et al. The predictive value of HLA-DR oligotyping for MLC responses. Transplantation 1992; 53: 1352-1357.
14. Mickelson EM, Longton G, Anasetti C et al. Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation. Tissue Antigens 1996; 47: 27-36.
15. Perkins HA, Hansen JA. The US National Marrow Donor Program. Am J Ped Hematol Oncol 1994; 16: 30-34.
16. Imanishi T, Akaza T, Kimura A et al. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T (eds). HLA 1991, vol. I. Oxford University Press: New York, 1992, pp 1065-1220.
17. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1994. Hum Immunol 1994; 41: 1-20.
18. Noreen H, Steiner L, Davidson M et al. Six new DPB1 alleles identified in a study of 1302 unrelated bone marrow donor-recipient pairs. Tissue Antigens 1997; 49: 512-516.
19. Howard MR, Gore SM, Hows JM et al. A prospective study of factors determining the outcome of unrelated marrow donor searches: report from the International Marrow Unrelated Search and Transplant Study Working Group on behalf of collaborating centres. Bone Marrow Transplant 1994; 13: 389-396.
20. Klitz W, Stephens JC, Grote M, Carrington M. Discordant patterns of linkage disequilibrium of the peptide-transporter loci within the HLA class II region. Am J Hum Genet 1995; 57: 1436-1444.
21. Salazar M, Yunis I, Alosco SM et al. HLA-DPB1 allele mismatches between unrelated HLA-A,B,C,DR (generic) DQA1-identical unrelated individuals with unreactive MLC. Tissue Antigens 1992; 39: 203-208.
22. Begovich AB, McClure GR, Suraj VC et al. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol 1992; 148: 249-258.
23. Szydlo R, Goldman JM, Klein JP et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-idenlical siblings. J Clin Oncol 1997; 15: 1767-1777.
24. Beurman SI, Mori M, Beatty PG et al. Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors. Bone Marrow Transplant 1994; 13: 31-35.
25. Davies SM, Ramsay NKC, Haake RJ et al. Comparison of engraftment in recipients of matched sibling or unrelated donor marrow allografts. Bone Marrow Transplant 1994; 13: 51-57.
26. Hansen JA, Gooley TA, Martin PJ et al. Bone marrow transplants from unrelated donors tor patients with chronic myeloid leukemia. New Engl J Med 1998; 338: 962-968.
27. Petersdorf EW, Gooley TA, Anasetti C et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998; 92: 3515-3520.
28. Sasazuki T, Juji T, Morishima Y et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. New Engl J Med 1998; 339: 1177-1185.
29. Petersdorf EW, Longton GM, Anasetti C et al. Definition of HLA-DQ as a transplantation antigen. Proc Natl Acad Sci USA 1996; 93: 15358-15363.
30. A1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201. Hum Immunol 1992; 34: 107-114.
31. Rosen-Bronson S, Jaraquemada D. On the relative immunogenicity of DR alloantigens: T cell recognition of HLA-DR2a and HLA-DR2b. Hum Immunol 1991; 30: 215-221.
32. Cotner T, Charbonneau H, Mellins E, Pious D. mRNA abundance, rather than differences in subunit assembly, determine differential expression of HLA-DRβ1 and -DRaβ3 molecules. J Biol Chem 1989; 264: 11107-11111.
33. Stunz LL, Karr RW, Anderson RA. HLA-DRB1 and -DRB4 genes are differentially regulated at the transcriptional level. J Immunol 1989; 143: 3081-3086.
34. Kratzin H, Yang CY, Gotz H et al. Primary structure of class II human histocompatibility antigens. 1st communication. Amino acid sequence of the N-terminal 198 residues of the beta chain of a HLA-Dw2,2; DR2,2-alloantigen. Hoppe Seylers Z Physiol Chem 1981; 362: 1665-1669.
35. Petersdorf EW, Smith AJ, Mickelson EM et al. The role of HLA-DPB1 disparity on the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood 1993; 81: 1923-1932.
36. Potolicchio I, Brookes PA, Madrigal A et al. HLA-DPB1 mismatch at position 69 is associated with high helper T lymphocyte precursor frequencies in unrelated hone marrow transplant pairs. Transplantation 1996; 62: 1347-1352.
37. Petersdorf EW, Longton GM, Anasetti C et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997; 89: 1818-1823.